[1] |
LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li.
Study on the relationship of stigma and social support of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
|
[2] |
WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia..
A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
|
[3] |
LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen.
Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
|
[4] |
LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu.
Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
|
[5] |
DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng..
Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
|
[6] |
LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui.
Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967.
|
[7] |
SHEN Xin, XIAO Xiao, BAI Li-qiong, PAN Qi-chao.
Interpretation of the Guidelines on management of close contacts of active pulmonary tuberculosis cases in schools
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 990-991.
|
[8] |
LI Ai-fang, CUI Xiao-li, KANG Lei, LEI Jing, DANG Li-yun, YANG Han.
Value of fluorescence PCR probe melting curve method in detecting resistance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 998-1001.
|
[9] |
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768.
|
[10] |
Beijing Chest Hospital, Capital Medical University, Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus on off-label use of drugs for non-tuberculous mycobacteria
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 769-787.
|
[11] |
ZHU Li-mei, CHEN Can-can, CHEN Wei, HU Xiao-guang, ZHANG Ya-nan, MA Jun-yang.
To formulate prevention and control strategy for latent tuberculosis infection population in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 794-798.
|
[12] |
YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang.
Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806.
|
[13] |
ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang.
Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813.
|
[14] |
ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang.
Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820.
|
[15] |
DU Wei-xin, WEI Fen, LU Jin-biao, ZHAO Ai-hua, PU Jiang, WANG Guo-zhi, XU Miao.
Preliminary establishment of national reference of the freeze-dried recombinant Mycobacterium tuberculosis allergen for the bulk potency evaluation
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 826-831.
|